Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Agnosia × Therapeutics × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 44 Neoplasms 39 Fatigue 29 Depression 25 Prostatic Neoplasms 20 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Lymphoma, Follicular 16 Carcinoma, Non-Small-Cell Lung 15 Multiple Myeloma 14 Lymphoma, Large B-Cell, Diffuse 14 Lung Neoplasms 14 Colorectal Neoplasms 14 Pain 13 Lymphoma, Non-Hodgkin 13 Leukemia, Lymphocytic, Chronic, B-Cell 13 Lymphoma, Mantle-Cell 12 Lymphoma, B-Cell, Marginal Zone 12 Leukemia, Myeloid, Acute 12 Hodgkin Disease 12 Burkitt Lymphoma 12 Lymphoma, Large-Cell, Immunoblastic 11 Anxiety Disorders 11 Lymphoma, T-Cell, Cutaneous 10 Leukemia, Myeloid, Chronic-Phase 10 Leukemia, Hairy Cell 10 Blast Crisis 10 Neoplasm Metastasis 9 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 9 Leukemia, Myeloid, Accelerated Phase 9 Head and Neck Neoplasms 9

Interventions

Bupivacaine 9 Ketamine 8 Analgesics, Opioid 8 Dexmedetomidine 7 Ropivacaine 6 Fentanyl 6 Anesthesia, General 6 Acetaminophen 6 Morphine 5 Lidocaine 5 Acupuncture Therapy 5 Tramadol 4 Surveys and Questionnaires 4 Sodium Chloride 4 Pregabalin 4 Ethanol 4 Anesthesia, Local 4 parecoxib 3 Saline Solution 3 Radiofrequency Ablation 3 Propofol 3 Ketorolac 3 Control Groups 3 Anesthetics, Local 3 Analgesia, Epidural 3 trimebutine 3-thiocarbamoylbenzenesulfonate 2 Transcutaneous Electric Nerve Stimulation 2 Tea 2 Oxycodone 2 Magnesium Sulfate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06947577 2025-08-20

PEMFTEPCHIN

Cairo University

Phase 4 Completed

Agnosia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡